Table 3.
Clinical Outcomes by caIMR and BMI.
| Total | Normal weight | Overweight | |||||||
|---|---|---|---|---|---|---|---|---|---|
| caIMR< 25 (n = 155) |
caIMR ≥ 25 (n = 127) |
P-value | caIMR< 25 (n = 70) |
caIMR ≥ 25 (n = 43) |
P-value | caIMR< 25 (n = 85) |
caIMR ≥ 25 (n = 84) |
P-value | |
| MACE | 10 (6.45) | 23 (18.11) | 0.003 | 4 (5.71) | 6 (13.95) | 0.176 | 6 (7.06) | 17 (20.24) | 0.014 |
| Cardiac death | 1 (0.65) | 0 | 1.000 | 0 | 0 | – | 1(1.18) | 0 | 1.000 |
| Revascularization | 6 (3.87) | 12 (9.45) | 0.084 | 2 (2.86) | 3 (6.98) | 0.367 | 4(4.71) | 9 (10.71) | 0.161 |
| Nonfatal MI | 2 (1.29) | 3 (2.36) | 0.660 | 1 (1.43) | 0 | 1.000 | 1(1.18) | 3 (3.57) | 0.368 |
| Heart failure | 1 (0.65) | 8 (6.30) | 0.012 | 1 (1.43) | 3 (6.98) | 0.153 | 0 | 5 (5.95) | 0.029 |
Values were shown as n (%). MACE, major adverse cardiac events; caIMR, coronary angiography-derived index of microcirculatory resistance; MI, myocardial infarction.